GlassScriptPhysician profile
Alexander F Mericli
NPI 1023252319
$124,817.31
in general payments reported to CMS, 2019-2025
17 companies · $34K in 2025
The $34K reported for 2025 was more than what 98% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $777 · 2020: $2,874 · 2021: $4,811 · 2022: $14K · 2023: $27K · 2024: $41K · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $89K · Food and Beverage: $6,612 · Travel and Lodging: $3,874 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,625 · Honoraria: $1,200 · Education: $42.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $88,626.33 |
| Food and Beverage | $6,611.56 |
| Travel and Lodging | $3,873.68 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,625.00 |
| Honoraria | $1,200.00 |
| Education | $42.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $77,750.92 | 2020-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Mentor Siltex Round Spectrum |
| Medical Device Business Services, INC. | $27,820.41 | 2020-2025 | |
| Abbvie INC. | $8,158.38 | 2023-2025 | |
| Tela Bio, INC. | $2,410.62 | 2019-2022 | |
| Allergan, INC. | $2,366.43 | 2019-2022 | |
| Integra Lifesciences Corporation | $1,878.64 | 2022-2025 | Codman Certas, Surgimend, Primatrix |
| Rti Surgical, INC | $1,293.30 | 2024-2025 | |
| Depuy Synthes Sales INC. | $741.30 | 2023-2025 | Matrixcombo, Na, Matrixmandible |
| Musculoskeletal Transplant Foundation INC. | $587.61 | 2023-2025 | |
| Axogen | $414.09 | 2019-2025 | Avance Nerve Graft |
| Sientra, INC. | $377.05 | 2020-2022 | |
| Baxter Healthcare | $294.75 | 2019-2022 | |
| Davol INC. | $183.17 | 2022 | |
| Stryker Corporation | $160.13 | 2024 | 1788 |
| Innovation Technologies INC | $158.33 | 2025 | Irrisept |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $130.39 | 2025 | |
| Kerecis Limited | $91.79 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Mericli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.